H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 16.5% of adults in McAllen have diagnosed diabetes — 4.5 points above the U.S. 12% figure. Census population 142,212. Texas Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed McAllen clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a McAllen storefront.
Growth Factor Therapy for Tissue Repair in McAllen, TX for clinics & physicians. Growth factor therapy pro… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 16.5% of adults in McAllen have diagnosed diabetes — 4.5 points above the U.S. 12% figure. Census city-proper population is 142,212. If you are adding growth factor therapy, start with that epidemiology and with Novitas Solutions (JH) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Growth Factor Therapy for Tissue Repair notes (how the product actually works)America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For McAllen we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 16.5% of adults in McAllen have diagnosed diabetes — 4.5 points above the U.S. 12% figure.
If you already buy growth factor therapy elsewhere, use this page as a check: homologous-use language, current Novitas Solutions article IDs, and PLACES 16.5% diabetes as the epidemiologic floor. If that is how you already practice, the catalog will fit.
CDC PLACES (2023, crude prevalence) estimates 16.5% of adults — 4.5 points above the U.S. 12% figure. Obesity is 41.8%; arthritis is 20.5%. That is place-level BRFSS modeling, not a clinic census and not a McAllen trial.
Hawk Medical works with independent reps who already have physician call points. Territory conversations start at /become-a-rep — not by scraping this city URL.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Texas compliance risk.
If you operate in Texas and another MAC state, say it on the first call. JH will not port 1:1. We would rather split utilization than watch a sister clinic copy McAllen tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in McAllen, TX.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for McAllen is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for McAllen — 4.5 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Texas Part B wound biologics follow this contractor (siblings: AR, CO, LA, MS, NM, OK). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in McAllen. Useful for joint-program math; still needs a diagnosis and privileging.
No McAllen storefront. Joe Bradley is an active practice owner. growth factor therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.